Readmissions and adverse drug reactions in internal medicine:: the economic impact

被引:94
作者
Dormann, H
Neubert, A
Criegee-Rieck, M
Egger, T
Radespiel-Tröger, M
Azaz-Livshits, T
Levy, M
Brune, K
Hahn, EG
机构
[1] Univ Erlangen Nurnberg, Med Klin & Poliklin 1, Dept Internal Med 1, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Expt & Clin Pharmacol & Toxicol, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Dept Med Informat & Biometry, Erlangen, Germany
[4] Hadassah Hebrew Univ, Med Ctr, Dept Clin Pharmacol, Jerusalem, Israel
关键词
adverse drug reaction; hospital readmission; information technology; pharmacovigilance; quality of care; resource utilization;
D O I
10.1111/j.1365-2796.2004.01326.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Recent studies show that nearly half of the hospitalized patients are readmitted within 6 months from discharge. No data exist about the relationship between adverse drug reactions (ADRs) and readmittance to a department of internal medicine. Objectives. The primary aims of the study were to determine if ADRs could be used as predictors for recurrent hospitalizations in internal medicine and to evaluate the economic impact of ADRs on hospitalization costs. Design and setting. A cohort-based, prospective, 18-month pharmacoepidemiological survey was conducted in the Department I of Internal Medicine at the University Hospital of Erlangen. All patients were intensively monitored for ADRs by a pharmacoepidemiological team. ADRs were evaluated for their offending drugs, probability, severity, preventability and classified by WHO-ART. During a 6-month period ADR-positive patients were matched to non-ADR patients applying diagnosis-related group categorization in order to measure the impact of ADRs on the duration and frequency of hospitalization. Results. Of 1000 admissions 424 patients had single admissions and 206 patients had recurrent readmissions (min 1, max 9). The prevalence of readmissions was 37% (n = 370). In 145 (23%) of 630 patients, 305 ADRs were observed. The ADR incidence was similar in first admissions and readmissions. ADRs were not found to predict further readmissions and lack of ADRs did not preclude readmissions. ADRs caused hospitalizations in 6.2% of first admissions and in 4.2% of readmissions. According to the Schumock algorithm 135 (44.3%) ADRs were found to be preventable. The occurrence and numbers of ADRs per admission were found to prolong hospitalization period significantly (r = 0.48 and 0.51, P < 0.001, n = 135). Of 9107 treatment days 20% were caused by in-house (1130 days) and community-acquired ADRs (669 days). In admissions and readmissions 11% (>973 days) of all treatment days were judged to be preventable. Conclusions. Intensified drug monitoring supported by information technology in internal medicine is essential for early detecting and prevention of ADRs and saving hospital resources.
引用
收藏
页码:653 / 663
页数:11
相关论文
共 43 条
[1]  
Ansari M Z, 1995, Aust Health Rev, V18, P63
[2]   Detecting adverse events using information technology [J].
Bates, DW ;
Evans, RS ;
Murff, H ;
Stetson, PD ;
Pizziferri, L ;
Hripcsak, G .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2003, 10 (02) :115-128
[3]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[4]  
Bean P, 1995, NURS MANAGE, V26, P67
[5]   Hospital readmissions as a measure of quality of health care -: Advantages and limitations [J].
Benbassat, J ;
Taragin, M .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (08) :1074-1081
[6]   DRUG-RELATED PROBLEMS CAUSING ADMISSION TO A MEDICAL CLINIC [J].
BERGMAN, U ;
WIHOLM, BE .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (03) :193-200
[7]   Analysis of the direct cost of adverse drug reactions in hospitalised patients [J].
Bordet, R ;
Gautier, S ;
Le Louet, H ;
Dupuis, B ;
Caron, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 56 (12) :935-941
[8]   INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I [J].
BRENNAN, TA ;
LEAPE, LL ;
LAIRD, NM ;
HEBERT, L ;
LOCALIO, AR ;
LAWTHERS, AG ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :370-376
[9]   Discharge destination and repeat hospitalizations [J].
Camberg, LC ;
Smith, NE ;
Beaudet, M ;
Daley, J ;
Cagan, M ;
Thibault, G .
MEDICAL CARE, 1997, 35 (08) :756-767
[10]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306